Trial NCT03330405

View at ClinicalTrials.gov 
Org. Study IDs: B9991025
Secondary IDs: 2017-001509-33 JAVELIN PARP MEDLEY

Last trial update was posted on 2023-10-13

MeSH Interventions

Antibodies, Monoclonal Avelumab Talazoparib

MeSH Conditions

Neoplasms

Other Conditions

Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors

Stopping Reasons

The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the investigational treatments have been moved to a continuation study (NCT05059522).

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID